211 related articles for article (PubMed ID: 35223547)
1. Effects of Live Combined
Pi X; Teng W; Fei D; Zhao G; Liu W
Front Cell Infect Microbiol; 2022; 12():821662. PubMed ID: 35223547
[TBL] [Abstract][Full Text] [Related]
2. Enterococcus faecium R-026 combined with Bacillus subtilis R-179 alleviate hypercholesterolemia and modulate the gut microbiota in C57BL/6 mice.
Huang J; Xu Y; Wang M; Yu S; Li Y; Tian H; Zhang C; Li H
FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 37960899
[TBL] [Abstract][Full Text] [Related]
3.
Huang J; Huang J; Yin T; Lv H; Zhang P; Li H
J Microbiol Biotechnol; 2021 Feb; 31(2):181-188. PubMed ID: 33144552
[No Abstract] [Full Text] [Related]
4. Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease.
Jiang J; Xiong J; Ni J; Chen C; Wang K
Med Sci Monit; 2021 Sep; 27():e931143. PubMed ID: 34482357
[TBL] [Abstract][Full Text] [Related]
5. Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules.
Lv L; Ruan G; Ping Y; Cheng Y; Tian Y; Xiao Z; Zhao X; Chen D; Wei Y
Front Cell Infect Microbiol; 2022; 12():1025889. PubMed ID: 36250045
[TBL] [Abstract][Full Text] [Related]
6.
Lv M; Lei Q; Yin H; Hu T; Wang S; Dong K; Pan H; Liu Y; Lin Q; Cao Z
Pol J Microbiol; 2021 Dec; 70(4):511-520. PubMed ID: 34970318
[TBL] [Abstract][Full Text] [Related]
7. Enterococcus faecium WEFA23 from infants lessens high-fat-diet-induced hyperlipidemia via cholesterol 7-alpha-hydroxylase gene by altering the composition of gut microbiota in rats.
Huang F; Zhang F; Xu D; Zhang Z; Xu F; Tao X; Qiu L; Wei H
J Dairy Sci; 2018 Sep; 101(9):7757-7767. PubMed ID: 29935822
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Live Combined
Guo L; Meng M; Wei Y; Lin F; Jiang Y; Cui X; Wang G; Wang C; Guo X
Front Pharmacol; 2018; 9():1506. PubMed ID: 30719003
[No Abstract] [Full Text] [Related]
9. Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model.
Duque ALRF; Demarqui FM; Santoni MM; Zanelli CF; Adorno MAT; Milenkovic D; Mesa V; Sivieri K
Food Res Int; 2021 Nov; 149():110657. PubMed ID: 34600659
[TBL] [Abstract][Full Text] [Related]
10. Parasite-Probiotic Interactions in the Gut:
Myhill LJ; Stolzenbach S; Mejer H; Krych L; Jakobsen SR; Kot W; Skovgaard K; Canibe N; Nejsum P; Nielsen DS; Thamsborg SM; Williams AR
Front Immunol; 2021; 12():793260. PubMed ID: 35069576
[TBL] [Abstract][Full Text] [Related]
11. Bacillus subtilis and Enterococcus faecium co-fermented feed regulates lactating sow's performance, immune status and gut microbiota.
Wang C; Wei S; Xu B; Hao L; Su W; Jin M; Wang Y
Microb Biotechnol; 2021 Mar; 14(2):614-627. PubMed ID: 33026173
[TBL] [Abstract][Full Text] [Related]
12. In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin.
Bianchi F; Larsen N; Tieghi TM; Adorno MAT; Saad SMI; Jespersen L; Sivieri K
Food Res Int; 2019 Jun; 120():595-602. PubMed ID: 31000276
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of selected synbiotics on the human faecal microbiota composition.
Saulnier DM; Gibson GR; Kolida S
FEMS Microbiol Ecol; 2008 Dec; 66(3):516-27. PubMed ID: 18673391
[TBL] [Abstract][Full Text] [Related]
14. Impacts of dietary silver nanoparticles and probiotic administration on the microbiota of an in-vitro gut model.
Cattò C; Garuglieri E; Borruso L; Erba D; Casiraghi MC; Cappitelli F; Villa F; Zecchin S; Zanchi R
Environ Pollut; 2019 Feb; 245():754-763. PubMed ID: 30500755
[TBL] [Abstract][Full Text] [Related]
15. Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model.
Shi Y; Zhai Q; Li D; Mao B; Liu X; Zhao J; Zhang H; Chen W
Microbiol Res; 2017 Jul; 200():14-24. PubMed ID: 28527760
[TBL] [Abstract][Full Text] [Related]
16. Two
Yao X; Nie W; Chen X; Zhang J; Wei J; Qiu Y; Liu K; Shao D; Liu H; Ma Z; Li Z; Li B
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791443
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
[TBL] [Abstract][Full Text] [Related]
18. Long-term and continuous administration of
Liu Y; Yin F; Huang L; Teng H; Shen T; Qin H
Food Funct; 2021 Mar; 12(5):2201-2210. PubMed ID: 33595001
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota and oral administration of Enterococcus faecium associated with the growth performance of new-born piglets.
Wang YB; Du W; Fu AK; Zhang XP; Huang Y; Lee KH; Yu K; Li WF; Li YL
Benef Microbes; 2016 Sep; 7(4):529-38. PubMed ID: 27089950
[TBL] [Abstract][Full Text] [Related]
20. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters.
Grimaldi R; Swann JR; Vulevic J; Gibson GR; Costabile A
Br J Nutr; 2016 Aug; 116(3):480-6. PubMed ID: 27267934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
